← Back to all signals
RESEARCH PAPER ANALYSIS

Chronic Disease and Disability in the United States: Trends, Inequities, and Imperatives for Policy Reform.

Using 2023 Global Burden of Disease and US Health Disparities estimates, this observational policy analysis reports growing chronic disability and substantial geographic, racial/ethnic, and educational health inequities in the United States and proposes broad education, environmental, obesity-management, behavioral-health, and data-infrastructure reforms.

Open original publication →
PMID42596762
JournalThe Milbank quarterly
Publication Date2026-08-14
Ingested2026-08-17 12:23 AM
EXECUTIVE SUMMARY

What the AI sees

Using 2023 Global Burden of Disease and US Health Disparities estimates, this observational policy analysis reports growing chronic disability and substantial geographic, racial/ethnic, and educational health inequities in the United States and proposes broad education, environmental, obesity-management, behavioral-health, and data-infrastructure reforms.

WHY IT MATTERS

Research significance

The record supports population-level associations and policy recommendations rather than a pediatric-oncology treatment hypothesis; at most, it can be inferred that addressing education, metabolic health, and structural inequities might indirectly improve long-term health among childhood cancer survivors, but this was not evaluated.

ABSTRACT

Source abstract

UNLABELLED: Policy Points Position Universal, High-Quality Education as a Foundational Public Health Strategy. Long-term health and life expectancy in the United States are shaped more by educational attainment than by any other single factor. Disparities in access to early childhood, K-12, and higher education perpetuate cycles of chronic disease, economic hardship, and shortened lifespan, particularly in marginalized communities. Policymakers must recognize education as a critical public health intervention and commit to providing universal access to high-quality education at every stage of life. This transformation requires shifting the focus from mere per-pupil spending toward the national scaling of high-impact instructional models, such as intensive, high-dosage tutoring and adaptive learning. Leveraging generative AI to provide personalized, real-time instruction tailored to individual student needs is essential to bridge the achievement gap at scale. Furthermore, achieving true educational equity requires decoupling school quality from local property taxes, integrating health literacy and nutrition into curricula, and ensuring higher education remains affordable and accessible for all. Transform the Food and Built Environment to Advance National Metabolic Resilience. The structure of America's food system and built environment directly fuels the escalating burden of obesity, diabetes, and related chronic diseases. Federal and state policies must fundamentally shift agricultural subsidies away from calorie-dense, nutrient-poor commodities toward specialty crops and fresh produce. To ensure these healthy choices are the default for every household, the federal government must finalize and enforce mandatory, interpretive front-of-package warning labels for ultra-processed foods. This shift, designed to move beyond the passive Nutrition Facts panel, will provide at-a-glance transparency and incentivize industrywide reformulation. Furthermore, metabolic health must be integrated into the K-12 experience through mandatory daily high-intensity physical activity to improve cardiorespiratory fitness and cognitive performance and minimally processed school meals. Finally, investments in active transportation infrastructure, including pedestrian greenways and safe routes to school, are essential to encourage movement as a default, closing the "convenience gap" that disproportionately burdens low-income and rural Americans. Normalize Chronic Obesity Management. Acknowledging that no nation has successfully reversed the obesity epidemic through behavioral advice alone, the United States must treat obesity as a chronic biological condition rather than a temporary lifestyle lapse. It is imperative that public and private payers guarantee universal, affordable access to evidence-based treatments, including next-generation pharmacotherapies (such as GLP-1 receptor agonists). These clinical strategies must be coupled with a modernized, real-time health data infrastructure to monitor outcomes and ensure equitable access at the neighborhood level. CONTEXT: Over the past three decades, mortality from leading causes such as cardiovascular disease and cancer has declined in the United States, but the burden of chronic, disabling conditions, including musculoskeletal disorders, mental and substance use disorders, and obesity, has grown or stagnated, widening the gap between total years lived and years lived in good health. These shifts are accompanied by persistent and widening inequities in longevity by geography, race/ethnicity, and socioeconomic status. METHODS: This analysis draws on the 2023 Global Burden of Disease Study, which estimates mortality, disability, and risk factor burden for 375 diseases and 88 risk factors nationally and at the state level, combined with findings from the US Health Disparities project. The latter uses small-area estimation to evaluate county-level life expectancy and mortality across five racial/ethnic groups and four educational strata, and the "Ten Americas" framework, which stratifies the population by race/ethnicity, geography, and socioeconomic context. FINDINGS: In 2023, US life expectancy reached 78.5 years and healthy life expectancy 64.5 years, both still below prepandemic 2019 levels, with a persistent 13-14-year gap between life expectancy and healthy life expectancy. Ischemic heart disease remained the leading cause of death, but drug use disorders rose from the 26th to the leading cause of disability, a 562% increase since 1990, while Alzheimer disease and musculoskeletal disorders also climbed in rank. High systolic blood pressure remained the top mortality risk factor despite a large decline, while high body mass index and high fasting plasma glucose burdens grew substantially. State-level disparities widened, with West Virginia and Mississippi trailing Hawaii by wide and increasing margins. Life expectancy gaps by race/ethnicity, education, and place were large and growing, reaching 20.4 years across the "Ten Americas" by 2021, with county-level life expectancy spanning more than 27 years nationally. CONCLUSIONS: US health trends reflect a shift from fatal to disabling disease, driven substantially by the obesity/metabolic and substance use epidemics, layered onto deep and widening structural inequities by race/ethnicity, place, and education. Reversing these trends requires a multidimensional policy agenda spanning universal, high-quality education; reform of the food and built environment; normalized clinical management of obesity; expanded, integrated substance use and mental health treatment; and modernized, real-time public health data infrastructure.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Randomized controlled trial of emotion regulation therapy versus cognitive behavioral therapy to address distress in cancer caregivers. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 83.64 2 Psychosocial mediators for the impact of personal genomic risk information on melanoma prevention and early detection behaviors. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 66.5 3 Cancer incidence and mortality in the Metropolitan Area of Bucaramanga, Colombia, 2013-2017. Colombia medica (Cali, Colombia) 39.0 4 Integrated multi-omic analysis of pediatric metastatic osteosarcoma reveals endothelial cell plasticity and lineage infidelity. bioRxiv : the preprint server for biology 46.5 5 Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL. Research square 61.86 6 Regional Consortia of Cancer Center Shared Resources: Models for Collaborative Infrastructure and the Emergence of a National Alliance. Journal of biomolecular techniques : JBT 54.0 7 Clinical Characteristics and Prognostic Analysis of Pediatric Acute Myeloid Leukemia With CBFB::MYH11: A 10-Year Single-Center Cohort Study. Clinical lymphoma, myeloma & leukemia 71.3 8 Distribution of molecular subtypes in a Colombian cohort of patients with acute lymphoblastic leukemia using whole-transcriptome analysis. Frontiers in oncology 56.0 9 Multimodality therapy for stage IB3 cervical cancer with a delayed diagnosis at 21 weeks of gestation: from neoadjuvant chemotherapy to adjuvant chemoradiotherapy-a case report. Frontiers in medicine 62.24 10 Association between perioperative factors and the occurrence of postoperative cerebellar mutism syndrome in children. Frontiers in neurology 60.5 11 Perceived community cervical cancer prevention support and cervical cancer screening utilization among women in Shenzhen, China: a cross-sectional study. Frontiers in public health 66.0 12 Retraction: PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults. Frontiers in oncology 66.24 13 Immediate comprehensive mandibular reconstruction with fibula free flap, implant-supported dental rehabilitation, and nerve reconstruction in children: A multicenter retrospective study. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 65.4 14 Fulminant Synchronous Epstein-Barr Virus-Positive MALT Lymphoma and Diffuse Large B-Cell Lymphoma Monomorphic Post-Transplant Lymphoproliferative Disorder in a Child Following Heart Transplant: A Case Report. Pediatric transplantation 55.9 15 Molecular Profiling and Clinical Characteristics of Breast Cancer in the Asir Region: a Retrospective Analysis. Clinical laboratory 64.9 16 Retrospective Analysis of HPV Infection Status and Genotyping in East China: 2023 - 2024. Clinical laboratory 57.5 17 Influence of predictors on postoperative quality of life in women with breast neoplasms. Revista brasileira de enfermagem 65.5 18 Outcomes of endoscopic sinus surgery (ESS) on sino-orbital osteomas: ophthalmic manifestations and visual outcomes from a 12-year multicenter experience and literature review. BMC ophthalmology 57.0 19 Risk of abnormal histology following vaginal hysterectomy for pelvic organ prolapse in a multi-ethnic Asian population: a two-year retrospective review. European journal of obstetrics, gynecology, and reproductive biology 61.4 20 Same-Day Radioembolization for Large Hepatocellular Carcinoma (≥ 5 cm) Using Yttrium-90 Resin Microspheres: Protocol for a Multicenter Prospective Registry Study (ISTAR-01). Cardiovascular and interventional radiology 66.0 21 Pediatric effects of forever chemicals may last for a long time. Pediatric research 60.7 22 Trajectories of pulmonary subsolid nodules in children and adolescents: a retrospective multicenter cohort study. European radiology 63.7 23 Targeting CD28 on T lineage malignancies with chimeric antigen receptor T cells. Nature communications 58.9 24 Efficacy of technology-based psychosocial interventions on quality of life and psychological outcomes in adolescent and young adult survivors of childhood cancer: a systematic review and meta-analysis of randomized controlled trials. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 77.7 25 Mental health struggles and coping strategies of individuals facing terminal illness of a loved one: A survey in a tertiary care hospital of Kolkata, West Bengal. Palliative & supportive care 61.0 26 Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression. Haematologica 52.5 27 Intracranial Mesenchymal Tumor With FET::CREB Fusion Involving Lateral Ventricle: A Case Report With Review of Literature. International journal of surgical pathology 47.5 28 Community-Led Solutions to Improve Cancer Outcomes for Indigenous Children. Pediatrics 47.5 29 Supratentorial ependymoma: a comprehensive review of molecular classification, management strategies, and clinical outcomes (Part II of pediatric ependymomas across compartments). Journal of neuro-oncology 81.9 30 Sex-dependent and long-term effects of cisplatin on bone mineral density in juvenile mice. Pharmacological reports : PR 50.9 31 Insights from a Multi-Country Survey: Healthcare Providers' Perspectives on the Management of Adults with Neurofibromatosis Type 1 and Plexiform Neurofibroma. Neurology and therapy 77.6 32 Efficacy and Safety of Alectinib in Pediatric and Adult Patients with ALK-Altered Advanced Solid Tumors: a phase II TACKLE Trial (NCCH1712/MK003). Clinical cancer research : an official journal of the American Association for Cancer Research 79.0
PATIENT-FRIENDLY SUMMARY

Chronic Disease and Disability in the United States: Trends, Inequities, and Imperatives for Policy Reform.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic